These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20032162)

  • 21. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
    Petkow-Dimitrow P; Klimeczek P; Vliegenthart R; Pasowicz M; Miszalski-Jamka T; Oudkerk M; Podolec P; Dubiel JS; Tracz W
    Kardiol Pol; 2009 Aug; 67(8A):964-9. PubMed ID: 19784900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Magnetic resonance imaging in hypertrophic cardiomyopathy (preliminary experience of 6 cases)].
    Zhang L
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Feb; 18(1):13-4, 60-1. PubMed ID: 2397688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stress hypoperfusion and tissue injury in hypertrophic cardiomyopathy: spatial characterization using high-resolution 3-tesla magnetic resonance imaging.
    Tyan CC; Armstrong S; Scholl D; Stirrat J; Blackwood K; El-Sherif O; Thompson T; Wisenberg G; Prato FS; So A; Lee TY; Drangova M; White JA
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):229-38. PubMed ID: 23413422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial late gadolinium enhancement is associated with raised serum amino-terminal propeptide of type III collagen concentrations in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha tropomyosin gene: magnetic resonance imaging study.
    Sipola P; Peuhkurinen K; Lauerma K; Husso M; Jääskeläinen P; Laakso M; Aronen HJ; Risteli J; Kuusisto J
    Heart; 2006 Sep; 92(9):1321-2. PubMed ID: 16908707
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiac magnetic resonance in hypertrophic cardiomyopathy.
    To AC; Dhillon A; Desai MY
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1123-37. PubMed ID: 21999873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An atypical case of cardiomyopathy in a child: hypertrophic or restrictive cardiomyopathy?
    Maki T; Niimura I; Nishikawa T; Sekiguchi M
    Heart Vessels Suppl; 1990; 5():84-7. PubMed ID: 2093723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mitochondrial cardiomyopathy in an adult: a case history].
    Tafanelli L; Avierinos JF; Thuny F; Pelissier JF; Jacquier A; Renard S; Amabile N; Gaubert JY; Habib G
    Arch Mal Coeur Vaiss; 2007 Dec; 100(12):1021-4. PubMed ID: 18223516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac amyloidosis presenting as pseudo-hypertrophic cardiomyopathy.
    Papachan A; Sliwa K; Gildenhuys A; Essop R
    Cardiovasc J S Afr; 2004; 15(3):136-8. PubMed ID: 15258625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [MR imaging in cardiomyopathies].
    Miller S; Riessen R
    Rofo; 2005 Nov; 177(11):1497-505. PubMed ID: 16302130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed hyper-enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: comparison with global and regional cardiac MR imaging appearances.
    Amano Y; Takayama M; Takahama K; Kumazaki T
    J Magn Reson Imaging; 2004 Oct; 20(4):595-600. PubMed ID: 15390225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gadolinium-enhanced cardiovascular magnetic resonance and exercise capacity in hypertrophic cardiomyopathy.
    Romero-Puche A; Marín F; González-Carrillo J; García-Honrubia A; Climent V; Feliu E; Ruiz-Espejo F; Payá E; Gimeno-Blanes JR; de la Morena G; Valdés-Chavarri M
    Rev Esp Cardiol; 2008 Aug; 61(8):853-60. PubMed ID: 18684368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrast-enhanced myocardial inversion time at the null point for detection of left ventricular myocardial fibrosis in patients with dilated and hypertrophic cardiomyopathy: a pilot study.
    Sueyoshi E; Sakamoto I; Uetani M
    AJR Am J Roentgenol; 2010 Apr; 194(4):W293-8. PubMed ID: 20308473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging.
    Harrigan CJ; Peters DC; Gibson CM; Maron BJ; Manning WJ; Maron MS; Appelbaum E
    Radiology; 2011 Jan; 258(1):128-33. PubMed ID: 21045187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac tumors: assessment with Gd-DTPA enhanced MR imaging.
    Funari M; Fujita N; Peck WW; Higgins CB
    J Comput Assist Tomogr; 1991; 15(6):953-8. PubMed ID: 1939774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging phenotype versus genotype in hypertrophic cardiomyopathy.
    Desai MY; Ommen SR; McKenna WJ; Lever HM; Elliott PM
    Circ Cardiovasc Imaging; 2011 Mar; 4(2):156-68. PubMed ID: 21406662
    [No Abstract]   [Full Text] [Related]  

  • 37. Determining the role of fibrosis in hypertrophic cardiomyopathy.
    Prinz C; Farr M; Laser KT; Esdorn H; Piper C; Horstkotte D; Faber L
    Expert Rev Cardiovasc Ther; 2013 Apr; 11(4):495-504. PubMed ID: 23570362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed-enhancement MRI of apical hypertrophic cardiomyopathy: assessment of the intramural distribution and comparison with clinical symptoms, ventricular arrhythmias, and cine MRI.
    Amano Y; Takayama M; Fukushima Y; Kitamura M; Kumita S
    Acta Radiol; 2011 Jul; 52(6):613-8. PubMed ID: 21498307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolated papillary muscle hypertrophy: a variant of hypertrophic cardiomyopathy? Do not miss a hypertrophic cardiomyopathy.
    Correia AS; Pinho T; Madureira AJ; Araujo V; Maciel MJ
    Eur Heart J Cardiovasc Imaging; 2013 Mar; 14(3):296. PubMed ID: 23002198
    [No Abstract]   [Full Text] [Related]  

  • 40. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.
    Flett AS; Hayward MP; Ashworth MT; Hansen MS; Taylor AM; Elliott PM; McGregor C; Moon JC
    Circulation; 2010 Jul; 122(2):138-44. PubMed ID: 20585010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.